Institutional Ownership Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM). We have compiled data on the 21 institutions that hold shares in the stock, with a total of 3.7 Million shares, which have been reported (via 13F filing form) to have a value of $28.6 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bml Capital Management, LLC
Zionsville, IN |
Apr 23, 2024 Q1 2024 |
2,193,742
shares
|
$16.9 Million
4.02% of portfolio
|
Q1 2024
Added 0.63%
|
|
Driehaus Capital Management LLC
Chicago, IL |
May 15, 2024 Q1 2024 |
811,680
shares
|
$6.26 Million
0.02% of portfolio
|
Q3 2023
Added 0.13%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
310,486
shares
|
$2.39 Million
0.0% of portfolio
|
Q4 2023
Added 0.21%
|
|
Atom Investors LP
Austin, TX |
May 15, 2024 Q1 2024 |
78,276
shares
|
$603,507
0.03% of portfolio
|
Q4 2023
Reduced 0.77%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
66,626
shares
|
$513,686
0.0% of portfolio
|
Q3 2023
Added 4.08%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2024 Q1 2024 |
55,223
shares
|
$425,769
0.0% of portfolio
|
Q3 2022
Added 170.4%
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
43,468
shares
|
$335,138
0.0% of portfolio
|
Q1 2024
Reduced 10.77%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
30,440
shares
|
$234,692
0.0% of portfolio
|
Q1 2024
Reduced 2.26%
|
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
May 15, 2024 Q1 2024 |
29,466
shares
|
$227,182
0.0% of portfolio
|
Q1 2024
Reduced 0.08%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
21,700
shares
|
$167,307
0.0% of portfolio
|
Q3 2023
Added 9.6%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
20,106
shares
|
$155,017
0.0% of portfolio
|
Q1 2024
Added 9.14%
|
|
Chicago Partners Investment Group LLC
|
Apr 25, 2024 Q1 2024 |
12,104
shares
|
$93,321
0.0% of portfolio
|
Q1 2024
Reduced 0.46%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
10,617
shares
|
$81,857
0.0% of portfolio
|
Q1 2024
Added 0.13%
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
May 10, 2024 Q1 2024 |
8,333
shares
|
$64,247
0.0% of portfolio
|
Q2 2023
New holding
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
5,925
shares
|
$45,681
0.0% of portfolio
|
Q1 2024
New holding
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2024 Q1 2024 |
3,606
shares
|
$27,802
0.0% of portfolio
|
Q1 2024
Added 4.37%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,709
shares
|
$13,176
0.0% of portfolio
|
Q2 2023
Reduced 97.26%
|
|
Qube Research & Technologies LTD
London, X0 |
May 14, 2024 Q1 2024 |
981
shares
|
$7,563
0.0% of portfolio
|
Q3 2023
New holding
|
|
Royal Bank Of Canada
Toronto, A6 |
May 15, 2024 Q1 2024 |
63
shares
|
$485
0.0% of portfolio
|
Q1 2024
Added 75.0%
|
|
Wells Fargo & Company
San Francisco, CA |
May 10, 2024 Q1 2024 |
50
shares
|
$385
0.0% of portfolio
|
Q1 2024
Added 4.17%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Apr 30, 2024 Q1 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|